Study of Using Optical Stimulated Luminescence (OSL)
in Clinical 3DCRT and IMRT Planning QA
Yang Wang 1,3, Carr Munoz-Ferrada 1,2,
Vivien Munoz-Ferrada 1,2, Bin Hu1,
William Zealey1
1.
2. Gammasonic
Research Institute, Sydney Australia
3. Radiation Oncology, St. Vincent¡¯s Private
Hospital Sydney,
Optical Stimulated Luminescence (OSL) is a
material with luminescent properties in a crystal structure that can absorb
radiation energy and temporarily keep the mobile electrons in an ionization
trap. The trapped electrons can be stimulated by a laser light then become a
countable amount of luminescence. The amount of luminescence is corresponding
to the radiation dose irradiated to the material. All procedure performed by a
designed laser reader we call this process is OSL dosimetry.
First report of OSL was published by Roy et
al (1997). The study of using OSL for radiation dose measurement in
radiotherapy was proposed by Huston et al in 1998 (In Vivo Radiotherapy Dose Monitoring System). In recent years, OSL
is widely used in radiation safety monitoring by stepping forward to replace
TLD technique. In radiotherapy clinical study, most research reports were
focused on In-Vivo real time dosimetry, as well the depth dose measurement with
point by point dose measurement in solid phantom (Marianne et al 2004 Phys. Med. Biol.). A common OSL material used is aluminium
oxide (Al2O3). This crystal structured material in
nowadays is not only can made into small peaces for point dose measurement,
also a shape as film, thing (0.2mm ¨C 0.4mm) flexible, and water proof.
This clinical study in
The characteristic result from the analysis
is showing that with different type of beam and energy, the dose response and
linearity to OSL are similar. The perfect dose linear range is from 0cGy to up
to 350cGy. The reasonable linear region could up to 1000cGy. The experiment
compared low dose rate (I-125 seeds) and 6MV photon beam. The reading
reproducibility and reliability tested by giving repeat 5 readings at 0cGy
(background) and 1000cGy material exposed. The result shows maximum 2.5% standard
deviation over average for no exposure background material, but maximum 0.5%
and average 0.3% for the readings from the OSL with given dose 1000cGy.
From the experiment result shows that the
characteristic of OSL as a new clinical dosimetry tool is capable to take the
place in real time dosimetry and planning QA checks. Compare OSL with TLD
technique, although the noise level is no showing significant differences, the
processing on saving time can be very big. Compare OSL sheet with EDR-2 film,
OSL has far better dose response range and linearity, low impact from art-fact.
Compare with small volume ionization chamber measurement in an IMRT phantom,
OSL could provide better flexibility on setting and with very small size of
reading point. The further study of this project is towards to the processing
of 2D dose scan analysis in 3DCRT and IMRT phantom. The OSL dosimetry in
radiotherapy is intend to combine point dose measurement, In-Vivo and iso-dose analysis into one as new QA technology tool in
radiotherapy clinical work.